AI in India's agriculture and healthcare sectors is a game-changer, boosting efficiency, accessibility, and economic growth, ...

Cretostimogene is an oncolytic immunotherapy with dual mechanism of action: viral replication leading to tumor lysis and release of granulocyte-macrophage colony stimulating factor.

Protara Therapeutics’ leading candidate is TARA-002, which so far looks like a promising immune-stimulating therapy derived ...

A healthy 30-year-old woman in Ireland was mistakenly injected with a BCG vaccine instead of an MMR shot, causing a severe TB ...

Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive ...

The median duration of response (DOR) exceeds 28 months and is ongoing, demonstrating the durability of cretostimogene's ...

BENGALURU: Health Minister Dinesh Gundu Rao on Tuesday announced the launch of a large-scale BCG (Bacille Calmette-Guerin) ...

NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle ...

Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer ...

Discover how a TB vaccine could revolutionise bladder cancer treatment. Find out more about this groundbreaking study.

Still, the IPO market holds promise due to a strong backlog of mature and high-quality private businesses eager for public ...